BioDiscovery introduces a major upgrade to its flagship NxClinical software system
Share Article
BioDiscovery, Inc. has recently released an upgraded version of their comprehensive, case-review solution for cytogenetics and molecular genetics.
I am very proud of this latest update to our NxClinical software which contains multiple inter-related functionalities that will provide unparalleled case-review capabilities to our customers. EL SEGUNDO, Calif. (PRWEB) February 11, 2021 Established genomic software leader BioDiscovery, Inc. has recently released an upgraded version of their comprehensive, case-review solution for cytogenetics and molecular genetics. With a continued focus on being platform agnostic and prioritizing customer feedback, the new release, NxClinical 6.0, is the company’s 5th major upgrade in the last 6 years. “I am very proud of this latest update to our NxClinical software which contains